- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 203/18 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms by carboxylic acids, or by sulfur or nitrogen analogues thereof
Patent holdings for IPC class C07D 203/18
Total number of patents in this class: 27
10-year publication summary
|
4
|
0
|
2
|
4
|
2
|
1
|
3
|
2
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| University of East Anglia | 33 |
4 |
| Duke University | 3164 |
3 |
| The University of North Carolina at Chapel Hill | 2075 |
3 |
| Canopy Growth Corporation | 211 |
2 |
| National Institute of Biological Sciences, Beijing | 100 |
2 |
| Zhejiang Hanmai Pharmaceutical Technology Co., Ltd. | 4 |
2 |
| Bristol-myers Squibb Company | 4812 |
1 |
| 3m Innovative Properties Company | 17509 |
1 |
| President and Fellows of Harvard College | 6044 |
1 |
| Dong-A Pharmaceutical Co., Ltd. | 79 |
1 |
| Japan Tobacco Inc. | 3506 |
1 |
| Latvian Institute of Organic Synthesis | 58 |
1 |
| Radikal Therapeutics Inc. | 8 |
1 |
| Sun Pharmaceutical Industries Limited | 723 |
1 |
| Mind Medicine Inc. | 40 |
1 |
| Autobahn Therapeutics, Inc. | 42 |
1 |
| Definium Therapeutics US, Inc. | 1 |
1 |
| Other owners | 0 |